{
  "metadata": {
    "experiment_name": "DNA_Damage_Panel_MultiGenotype",
    "date": "2024-01-15",
    "researcher": "Your Name",
    "description": "DNA damage panel analysis across multiple genotypes and DNA-damaging compounds",
    "control_label": "DMSO",
    "dilut_column": "Dilut",
    "output_dir": "./dna_damage_analysis_output",
    "notes": "3x dilution series, varying starting doses per compound"
  },
  "genotypes": {
    "WT": {
      "description": "Wild-type control cells",
      "drugs": {
        "Etoposide": {
          "path": "/path/to/data/WT_Etoposide_single_cell_features.parquet",
          "ec50_um": 1.5,
          "max_dose": "100uM",
          "moa": "Topoisomerase II inhibitor",
          "dilution_factor": 3.0,
          "notes": "Induces DSBs via TopoII poisoning"
        },
        "Camptothecin": {
          "path": "/path/to/data/WT_Camptothecin_single_cell_features.parquet",
          "ec50_um": 0.5,
          "max_dose": "33uM",
          "moa": "Topoisomerase I inhibitor",
          "dilution_factor": 3.0,
          "notes": "Induces SSBs that convert to DSBs during replication"
        },
        "Cisplatin": {
          "path": "/path/to/data/WT_Cisplatin_single_cell_features.parquet",
          "ec50_um": 5.0,
          "max_dose": "100uM",
          "moa": "DNA crosslinker",
          "dilution_factor": 3.0,
          "notes": "Forms intra- and inter-strand crosslinks"
        },
        "Doxorubicin": {
          "path": "/path/to/data/WT_Doxorubicin_single_cell_features.parquet",
          "ec50_um": 0.3,
          "max_dose": "10uM",
          "moa": "TopoII inhibitor + intercalator",
          "dilution_factor": 3.0,
          "notes": "Multiple mechanisms including ROS generation"
        },
        "Bleomycin": {
          "path": "/path/to/data/WT_Bleomycin_single_cell_features.parquet",
          "ec50_um": 2.0,
          "max_dose": "100uM",
          "moa": "Radiomimetic",
          "dilution_factor": 3.0,
          "notes": "Generates DSBs similar to ionizing radiation"
        },
        "Hydroxyurea": {
          "path": "/path/to/data/WT_Hydroxyurea_single_cell_features.parquet",
          "ec50_um": 500.0,
          "max_dose": "10mM",
          "moa": "Ribonucleotide reductase inhibitor",
          "dilution_factor": 3.0,
          "notes": "Causes replication stress and fork stalling"
        }
      }
    },
    "BRCA1_KO": {
      "description": "BRCA1 knockout - HR deficient",
      "drugs": {
        "Etoposide": {
          "path": "/path/to/data/BRCA1_KO_Etoposide_single_cell_features.parquet",
          "ec50_um": 0.8,
          "max_dose": "100uM",
          "moa": "Topoisomerase II inhibitor",
          "dilution_factor": 3.0
        },
        "Camptothecin": {
          "path": "/path/to/data/BRCA1_KO_Camptothecin_single_cell_features.parquet",
          "ec50_um": 0.2,
          "max_dose": "33uM",
          "moa": "Topoisomerase I inhibitor",
          "dilution_factor": 3.0
        },
        "Cisplatin": {
          "path": "/path/to/data/BRCA1_KO_Cisplatin_single_cell_features.parquet",
          "ec50_um": 1.5,
          "max_dose": "100uM",
          "moa": "DNA crosslinker",
          "dilution_factor": 3.0
        },
        "Doxorubicin": {
          "path": "/path/to/data/BRCA1_KO_Doxorubicin_single_cell_features.parquet",
          "ec50_um": 0.1,
          "max_dose": "10uM",
          "moa": "TopoII inhibitor + intercalator",
          "dilution_factor": 3.0
        },
        "Bleomycin": {
          "path": "/path/to/data/BRCA1_KO_Bleomycin_single_cell_features.parquet",
          "ec50_um": 0.5,
          "max_dose": "100uM",
          "moa": "Radiomimetic",
          "dilution_factor": 3.0
        }
      }
    },
    "p53_KO": {
      "description": "p53 knockout - checkpoint deficient",
      "drugs": {
        "Etoposide": {
          "path": "/path/to/data/p53_KO_Etoposide_single_cell_features.parquet",
          "ec50_um": 2.5,
          "max_dose": "100uM",
          "moa": "Topoisomerase II inhibitor",
          "dilution_factor": 3.0
        },
        "Camptothecin": {
          "path": "/path/to/data/p53_KO_Camptothecin_single_cell_features.parquet",
          "ec50_um": 0.8,
          "max_dose": "33uM",
          "moa": "Topoisomerase I inhibitor",
          "dilution_factor": 3.0
        },
        "Cisplatin": {
          "path": "/path/to/data/p53_KO_Cisplatin_single_cell_features.parquet",
          "ec50_um": 8.0,
          "max_dose": "100uM",
          "moa": "DNA crosslinker",
          "dilution_factor": 3.0
        },
        "Doxorubicin": {
          "path": "/path/to/data/p53_KO_Doxorubicin_single_cell_features.parquet",
          "ec50_um": 0.5,
          "max_dose": "10uM",
          "moa": "TopoII inhibitor + intercalator",
          "dilution_factor": 3.0
        }
      }
    },
    "ATM_KO": {
      "description": "ATM knockout - DSB signaling deficient",
      "drugs": {
        "Etoposide": {
          "path": "/path/to/data/ATM_KO_Etoposide_single_cell_features.parquet",
          "ec50_um": 0.5,
          "max_dose": "100uM",
          "moa": "Topoisomerase II inhibitor",
          "dilution_factor": 3.0
        },
        "Bleomycin": {
          "path": "/path/to/data/ATM_KO_Bleomycin_single_cell_features.parquet",
          "ec50_um": 0.3,
          "max_dose": "100uM",
          "moa": "Radiomimetic",
          "dilution_factor": 3.0
        },
        "Doxorubicin": {
          "path": "/path/to/data/ATM_KO_Doxorubicin_single_cell_features.parquet",
          "ec50_um": 0.08,
          "max_dose": "10uM",
          "moa": "TopoII inhibitor + intercalator",
          "dilution_factor": 3.0
        }
      }
    }
  }
}
